Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data

BACKGROUND: Diabetic macular edema (DME) shows a gradual and sustained functional and morphologic response to anti-vascular endothelial growth factor (VEGF) drugs, but the optimal schedule for initiation of anti-VEGF therapy is not known. This study evaluates the treatment response behavior of DME i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemssen, Focke, Schlottman, Patricio G., Lim, Jennifer I., Agostini, Hansjürgen, Lang, Gabriele E., Bandello, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088462/
https://www.ncbi.nlm.nih.gov/pubmed/27847634
http://dx.doi.org/10.1186/s40942-016-0041-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088462/
https://www.ncbi.nlm.nih.gov/pubmed/27847634
http://dx.doi.org/10.1186/s40942-016-0041-z

Ejemplares similares